The overall objective of this proposal is to understand the role of the endocytosis and metabolism of insulin-receptor complexes in insulin action. Further understanding in this area is essential for the eventual elucidation of the pathophysiology of insulin resistant states such as type II diabetes mellitus and obesity. Insulin initiates all of its diverse biologic actions by first binding to the high affinity insulin receptor, a glycoprotein macromolecule on the surface of target cells. This process activates the receptor as a kinase towards other substrates and also rapidly induces the internalization of the bound insulin- receptor complexes. At present, the role of the internalization process in insulin action remains poorly understood and the objective of this project is to contribute to further understanding in this important area of investigation. Accordingly, the following specific aims will be pursued: (1) To identify the structural domain of human insulin receptor which mediates its internalization and processing; (2) To generate receptor mutants defective in internalization but retaining kinase function; and (3) using such mutants, to determine the functional role of internalization of insulin-receptor complexes in insulin action on metabolic processes. The insulin-stimulated metabolic functions to be examined will include: stimulation of glucose uptake (a rapid transmembrane effect); stimulation of glycogen and protein synthesis (effects of intermediate duration); and stimulation of RNA and DNA synthesis (longer-term effects). In pursuing these aims, extensive cellular, biochemical, and molecular biological methodologies will be utilized. In brief, these will include cell culture, receptor photoaffinity labeling/processing, biosynthetic labeling, generation of receptor mutants, and measurements of several insulin-stimulated biologic functions. It is hoped that he results of the proposed studies will lead to a better understanding of the mechanism of insulin action and thereby contribute to the eventual elucidation of the pathophysiology of insulin resistance, a major abnormality in obesity and type II diabetes mellitus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK032880-05A3
Application #
3231240
Study Section
Metabolism Study Section (MET)
Project Start
1983-08-01
Project End
1992-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Berhanu, P; Anderson, C; Hickman, M et al. (1997) Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation. J Biol Chem 272:22884-90
Schranz, D B; Rohilla, A M; Anderson, C et al. (1996) Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects. Biochem Biophys Res Commun 227:600-7
Berhanu, P; Anderson, C; Paynter, D R et al. (1995) The amino acid sequence GPLY is not necessary for normal endocytosis of the human insulin receptor B isoform. Biochem Biophys Res Commun 209:730-8
Staubs, P A; Reichart, D R; Saltiel, A R et al. (1994) Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP. J Biol Chem 269:27186-92
Berhanu, P; Ibrahim-Schneck, R H; Anderson, C et al. (1991) The NPEY sequence is not necessary for endocytosis and processing of insulin-receptor complexes. Mol Endocrinol 5:1827-35
Rohilla, A M; Anderson, C; Wood, W M et al. (1991) Insulin downregulates the steady-state level of its receptor's messenger ribonucleic acid. Biochem Biophys Res Commun 175:520-6
Berhanu, P; Rohilla, A M; Rutter, W J (1990) Replacement of the human insulin receptor transmembrane and cytoplasmic domains by corresponding domains of the oncogene product v-ros leads to accelerated internalization, degradation, and down-regulation. J Biol Chem 265:9505-11
Sassa, S (1988) Heme stimulation of cellular growth and differentiation. Semin Hematol 25:312-20